title: Exenterative pelvic surgery--eleven year experience of the Swansea Pelvic Oncology Group.
abstract: OBJECTIVE
  To review indications for surgery and outcomes of patients with complex locally advanced pelvic malignancies treated by a multidisciplinary Pelvic Oncology Group.
  
  
  METHODS
  Between March 1992 and March 2003, 130 patients were jointly assessed in a monthly clinic involving urological, gynaecological, colorectal and plastic surgeons, an oncologist and nurse specialists. Seventy-six patients proceeded to exenterative surgery.
  
  
  RESULTS
  Rectal carcinoma and gynaecological cancers were the two most common indications for surgery. Median follow-up was 14 months (range 1-120 months). There were no deaths within 30 days of surgery. The morbidity rate was 28%. Predicted 5 years survival was 53% in cases with clear histological margins and no lymph node metastasis.
  
  
  CONCLUSIONS
  With careful patient selection and multi specialty care pelvic exenteration is a safe and effective option in the treatment of complex locally advanced pelvic malignancy.
authors.affiliation: Swansea Pelvic Oncology Group, Singleton and Morriston Hospitals, Swansea, UK. daiqanguyen@hotmail.com
authors.forename: D Q A
authors.initials: DQ
authors.lastname: Nguyen
authors.forename: A D
authors.initials: AD
authors.lastname: McGregor
authors.forename: O
authors.initials: O
authors.lastname: Freites
authors.forename: N D
authors.initials: ND
authors.lastname: Carr
authors.forename: J
authors.initials: J
authors.lastname: Beynon
authors.forename: A M M
authors.initials: AM
authors.lastname: El-Sharkawi
authors.forename: M G
authors.initials: MG
authors.lastname: Lucas
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010348:Patient Care Team; D018579:Patient Selection; D010385:Pelvic Exenteration / Q000401:mortality*; D010386:Pelvic Neoplasms / Q000401:mortality / Q000601:surgery*; D016019:Survival Analysis; D016896:Treatment Outcome